Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Avidity Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 6 | -$1.01 | -$0.73 | -$0.88 |
| Q2 2025 | 3 | -$0.91 | -$0.91 | -$0.91 |
| Q3 2025 | 3 | -$0.97 | -$0.97 | -$0.97 |
| Q4 2025 | 3 | -$1.03 | -$1.03 | -$1.03 |
| Q1 2026 | 4 | -$0.99 | -$0.99 | -$0.99 |
| Q2 2026 | 3 | -$1.03 | -$1.03 | -$1.03 |
| Q3 2026 | 3 | -$1.09 | -$1.09 | -$1.09 |
| Q4 2026 | 4 | -$1.14 | -$1.14 | -$1.14 |
Avidity Biosciences, Inc. Earnings Date And Information
Avidity Biosciences, Inc. last posted its earnings results on Thursday, February 27th, 2025. The company reported $-0.8 earnings per share for the quarter, missing analysts' consensus estimates of $-0.76 by $0.04. The company had revenue of 2.97 M for the quarter and had revenue of 10.90 M for the year. Avidity Biosciences, Inc. has generated $-3 earnings per share over the last year ($-2.89 diluted earnings per share) and currently has a price-to-earnings ratio of -9.89. Avidity Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 7th, 2025 based on prior year's report dates.
Avidity Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/27/2025 | Q4 2024 | -$0.76 | -$0.80 | -0.04 | $1.63 M | $2.97 M |
| 09/30/2024 | Q3 2024 | N/A | -$0.65 | N/A | $4.07 M | $2.34 M |
| 08/09/2024 | Q2 2024 | -$0.76 | -$0.66 | 0.1 | $2.63 M | $2.05 M |
| 05/09/2024 | Q1 2024 | -$0.81 | -$0.79 | 0.02 | $2.57 M | $3.54 M |
| 02/28/2024 | Q4 2023 | -$0.54 | -$0.79 | -0.25 | $12.21 M | $2.19 M |
| 11/08/2023 | Q3 2023 | -$0.76 | -$0.71 | 0.05 | $2.21 M | $2.82 M |
| 08/08/2023 | Q2 2023 | -$0.84 | -$0.66 | 0.18 | $2.14 M | $2.32 M |
| 05/09/2023 | Q1 2023 | -$0.90 | -$0.67 | 0.23 | $2.04 M | $2.23 M |
| 02/28/2023 | Q4 2022 | -$0.84 | -$0.83 | 0.01 | $2.16 M | $2.77 M |
| 11/08/2022 | Q3 2022 | -$0.97 | -$0.80 | 0.17 | $2.13 M | $2.48 M |
| 08/09/2022 | Q2 2022 | -$0.74 | -$0.92 | -0.18 | $2.11 M | $2.18 M |
| 05/10/2022 | Q1 2022 | -$0.94 | -$0.71 | 0.23 | $1.90 M | $1.80 M |
| 03/01/2022 | Q4 2021 | -$0.73 | -$1.63 | -0.9 | $2.18 M | $1.85 M |
| 11/09/2021 | Q3 2021 | -$0.63 | -$0.68 | -0.05 | $2.13 M | $2.16 M |
| 08/09/2021 | Q2 2021 | -$0.77 | -$0.70 | 0.07 | $1.94 M | $2.61 M |
| 05/12/2021 | Q1 2021 | -$0.52 | -$0.64 | -0.12 | $1.00 M | $2.70 M |
| 03/15/2021 | Q4 2020 | -$0.34 | -$0.43 | -0.09 | $838,750 | $2.14 M |
| 11/10/2020 | Q3 2020 | -$0.32 | -$0.31 | 0.01 | $575,000 | $1.75 M |
| 08/11/2020 | Q2 2020 | N/A | -$1.23 | N/A | $700,000 | $1.54 M |
| 03/30/2020 | Q1 2020 | N/A | -$0.20 | N/A | N/A | $1.36 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Avidity Biosciences, Inc. Earnings: FAQ's
Avidity Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 7th, 2025 based offlast year's report dates.
The conference call for Avidity Biosciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Avidity Biosciences, Inc.'s latest earnings report can be read online.
Avidity Biosciences, Inc. (:RNA) has a recorded annual revenue of $10.90 M.
Avidity Biosciences, Inc. (:RNA) has a recorded net income of $-322,302,000.Avidity Biosciences, Inc. has generated $-2.89 earnings per share over the last four quarters.
Avidity Biosciences, Inc. (:RNA) has a price-to-earnings ratio of -9.89 and price/earnings-to-growth ratio is 28.57.